BACKGROUND: Methylation of deoxyribonucleic acid (DNA) is an epigenetic regulator of gene expression that changes with age, but its contribution to aging-related disorders, including high blood pressure (BP), is still largely unknown. We examined the relation of BP to the methylation of retrotransposon sequences of DNA and of selected candidate genes. METHODS: This investigation included 789 elderly participants in the Normative Aging Study, ranging in age from 55 to 100 years, who had longitudinal measurements of DNA methylation. In these subjects' DNA we measured the proportion of methylated sites in retrotransposable sequences and in pro-inflammatory genes, expressed as the percent of 5-methylated cytosines (%5mC) among all cytosines. From one to four methylation measurements were made for each subject between 1999 and 2009. We fit mixed-effects models, using repeated measures of BP as the outcome and DNA methylation as the explanatory variable, adjusting for confounding variables. We also fit a Bayesian mixed-effects structural equation model to account for heterogeneity in the effects of methylation sites within each gene. RESULTS: An increase in inter-quartile range (IQR) in the methylation of Alu elements was associated with an increase of 0.97 mm Hg in diastolic blood pressure (DBP) (95% CI 0.32-1.57), but no such association was observed for long interspersed nuclear element-1 (LINE-1). We also found positive associations between DBP and methylation of the genes for toll-like receptor 2 (TLR2) and inducible nitric oxide synthase (iNOS), and a negative association between DBP and methylation of the gene for interferon-γ (IFN-γ). Associations between methylation and systolic blood pressure (SBP) were weaker than those between methylation and DBP. Bayesian mixed-effects structural equation model results were similar for both DBP and SBP models. CONCLUSIONS: The results of our study suggest that changes in DNA methylation of some pro-inflammatory genes and retrotransposable elements are related to small changes in BP.
BACKGROUND: Methylation of deoxyribonucleic acid (DNA) is an epigenetic regulator of gene expression that changes with age, but its contribution to aging-related disorders, including high blood pressure (BP), is still largely unknown. We examined the relation of BP to the methylation of retrotransposon sequences of DNA and of selected candidate genes. METHODS: This investigation included 789 elderly participants in the Normative Aging Study, ranging in age from 55 to 100 years, who had longitudinal measurements of DNA methylation. In these subjects' DNA we measured the proportion of methylated sites in retrotransposable sequences and in pro-inflammatory genes, expressed as the percent of 5-methylated cytosines (%5mC) among all cytosines. From one to four methylation measurements were made for each subject between 1999 and 2009. We fit mixed-effects models, using repeated measures of BP as the outcome and DNA methylation as the explanatory variable, adjusting for confounding variables. We also fit a Bayesian mixed-effects structural equation model to account for heterogeneity in the effects of methylation sites within each gene. RESULTS: An increase in inter-quartile range (IQR) in the methylation of Alu elements was associated with an increase of 0.97 mm Hg in diastolic blood pressure (DBP) (95% CI 0.32-1.57), but no such association was observed for long interspersed nuclear element-1 (LINE-1). We also found positive associations between DBP and methylation of the genes for toll-like receptor 2 (TLR2) and inducible nitric oxide synthase (iNOS), and a negative association between DBP and methylation of the gene for interferon-γ (IFN-γ). Associations between methylation and systolic blood pressure (SBP) were weaker than those between methylation and DBP. Bayesian mixed-effects structural equation model results were similar for both DBP and SBP models. CONCLUSIONS: The results of our study suggest that changes in DNA methylation of some pro-inflammatory genes and retrotransposable elements are related to small changes in BP.
Authors: Rita Castro; Isabel Rivera; Eduard A Struys; Erwin E W Jansen; Paula Ravasco; Maria Ermelinda Camilo; Henk J Blom; Cornelis Jakobs; Isabel Tavares de Almeida Journal: Clin Chem Date: 2003-08 Impact factor: 8.327
Authors: Mikko O Hiltunen; Mikko P Turunen; Tomi P Häkkinen; Juha Rutanen; Maria Hedman; Kimmo Mäkinen; Anna-Mari Turunen; Katriina Aalto-Setälä; Seppo Ylä-Herttuala Journal: Vasc Med Date: 2002-02 Impact factor: 3.239
Authors: Karen Huen; Antonia M Calafat; Asa Bradman; Paul Yousefi; Brenda Eskenazi; Nina Holland Journal: Environ Res Date: 2016-03-25 Impact factor: 6.498
Authors: Valentina Gonzalez-Jaramillo; Eliana Portilla-Fernandez; Marija Glisic; Trudy Voortman; Wichor Bramer; Rajiv Chowdhury; Anton J M Roks; A H Jan Danser; Taulant Muka; Jana Nano; Oscar H Franco Journal: J Hum Hypertens Date: 2019-07-25 Impact factor: 3.012
Authors: Tao Gao; Brian Thomas Joyce; Lei Liu; Yinan Zheng; Qi Dai; Zhou Zhang; Wei Zhang; Martha J Shrubsole; Meng-Hua Tao; Joel Schwartz; Andrea Baccarelli; Lifang Hou Journal: Am J Cancer Res Date: 2016-01-15 Impact factor: 6.166